Company Description:
Building Products & Materials Firm
Building Products & Materials Firm
Construction Executive Online
Construction Job Openings
Company News
- Oxygen Biotherapeutics, Inc. : Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and Webcast - marketscreener.com (news.google.com)
- Geosynthetics Market Deep Research Report with Forecast by 2032 - openPR.com (news.google.com)
- Geosynthetics Market to Reach USD 26 Billion by 2032, - openPR.com (news.google.com)
- What is Leerink Partnrs’ Forecast for TENX Q1 Earnings? - Defense World (news.google.com)
- Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - Yahoo Finance (news.google.com)
- Tenax Therapeutics: Q4 Earnings Snapshot - marketscreener.com (news.google.com)
- Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire (news.google.com)
- Tenax Raises Massive $125M War Chest: Phase 3 Heart Failure Drug Trial Gets Major Boost - Stock Titan (news.google.com)
- Geocomposites Market Is Booming So Rapidly | Tenax, Raven, Tensar - openPR.com (news.google.com)
- Tenax Secures FDA Green Light for Dual Phase 3 Trials in Untreated Heart Condition - Stock Titan (news.google.com)
- Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing - GlobeNewswire (news.google.com)
- Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewswire (news.google.com)
- Tenax Therapeutics Appoints Gillian Andor Vice President, Clinical Operations - GlobeNewswire (news.google.com)
- Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewswire (news.google.com)
- Geosynthetics Market to Witness Huge Growth by 2032 - openPR.com (news.google.com)
- Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update - Yahoo Finance (news.google.com)
- Tenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program - Yahoo Finance (news.google.com)
- Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement - GlobeNewswire (news.google.com)
- Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - Diagnostic and Interventional Cardiology (news.google.com)
- Tenax Therapeutics Announces New U.S. Patent Covering the - GlobeNewswire (news.google.com)
- Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan - GlobeNewswire (news.google.com)
- Tenax Therapeutics Announces Reverse Stock Split - Stock Titan (news.google.com)
- Tenax Therapeutics Announces Reverse Stock Split - GlobeNewswire (news.google.com)
- Albina Rose Arconti Obituary - Danbury, CT - Dignity Memorial (news.google.com)
- Geosynthetics Market to be Worth USD 40.7 billion by 2031: Exclusive Report by Transparency Market Research - GlobeNewswire (news.google.com)
- Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - Diagnostic and Interventional Cardiology (news.google.com)
- Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan - GlobeNewswire (news.google.com)
- Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in PH-HFpEF - Diagnostic and Interventional Cardiology (news.google.com)
- Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - Diagnostic and Interventional Cardiology (news.google.com)
- Tenax Therapeutics Announces Reverse Stock Split - citybiz (news.google.com)
- Sun Capital Partners Affiliate Acquires TENAX - Business Wire (news.google.com)
- Tenax plans $1 million in upgrades, new jobs at rural Conecuh plant - Made in Alabama (news.google.com)
- TENX: TNX-103 & TNX-201 Near Ready for Phase III - Yahoo Finance (news.google.com)
- Tenax Therapeutics Appoints Christopher T. Giordano as CEO - citybiz (news.google.com)
- $774,000 verdict for worker injured in Evergreen plant - AL.com (news.google.com)
- Toho Tenax develops multi-material roof cover for Toyota - Innovation in Textiles (news.google.com)
- Toho Tenax’s prepreg used to cut electric racecar’s weight - Innovation in Textiles (news.google.com)
- Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics (NASDAQ: TENX) - Business Wire (news.google.com)
- Joan Carpenter Obituary - Monroe, CT - Dignity Memorial (news.google.com)